{
    "meta": {
        "totalResults": 3,
        "from": 0
    },
    "results": [
        {
            "aliases": [
                {
                    "type": "Synonym",
                    "name": "PPAR-gamma agonist CS-7017"
                },
                {
                    "type": "CodeName",
                    "name": "CS-7017"
                },
                {
                    "type": "Synonym",
                    "name": "inolitazone dihydrochloride"
                },
                {
                    "type": "CodeName",
                    "name": "RS5444"
                },
                {
                    "type": "CASRegistryName",
                    "name": "223132-38-5"
                },
                {
                    "type": "ChemicalStructureName",
                    "name": "2,4-thiazolidinedione, 5-((4-((6-(4-amino-3,5-dimethylphenoxy)-1-methyl-1h-benzimidazol-2-yl)methoxy)phenyl)methyl)-, Hydrochloride (1:2)"
                }
            ],
            "definition": {
                "html": "The dihydrochloride salt of efatutazone, an orally bioavailable agonist of peroxisome proliferator-activated receptor gamma (PPAR-gamma) with potential antineoplastic activity. Efatutazone binds to and activates PPAR-gamma, a nuclear hormone receptor and a ligand-activated transcription factor controling gene expression involved in macromolecule metabolism and cell differentiation, specifically adipocyte differentiation. Mediated through activation of PPAR-gamma, this agent is capable of inducing cell differentiation and apoptosis, thereby leading to a reduction in cellular proliferation. ",
                "text": "The dihydrochloride salt of efatutazone, an orally bioavailable agonist of peroxisome proliferator-activated receptor gamma (PPAR-gamma) with potential antineoplastic activity. Efatutazone binds to and activates PPAR-gamma, a nuclear hormone receptor and a ligand-activated transcription factor controling gene expression involved in macromolecule metabolism and cell differentiation, specifically adipocyte differentiation. Mediated through activation of PPAR-gamma, this agent is capable of inducing cell differentiation and apoptosis, thereby leading to a reduction in cellular proliferation. "
            },
            "drugInfoSummaryLink": null,
            "nciConceptId": "C64764",
            "nciConceptName": "Efatutazone Dihydrochloride",
            "termId": 529846,
            "name": "efatutazone dihydrochloride",
            "firstLetter": "e",
            "type": "DrugTerm",
            "termNameType": "PreferredName",
            "prettyUrlName": "efatutazone-dihydrochloride"
        },
        {
            "aliases": [
                {
                    "type": "ChemicalStructureName",
                    "name": "(+/-)-5-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione, ( Z )-2-Butenedioate (1:1)"
                },
                {
                    "type": "CodeName",
                    "name": "BRL49653"
                },
                {
                    "type": "USBrandName",
                    "name": "Avandia"
                },
                {
                    "type": "Abbreviation",
                    "name": "ROS"
                }
            ],
            "definition": {
                "html": "The maleate salt of rosiglitazone, an orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. Rosiglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis. This agent also modulates the transcription of insulin-responsive genes, inhibits macrophage and monocyte activation, and stimulates adipocyte differentiation.",
                "text": "The maleate salt of rosiglitazone, an orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. Rosiglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis. This agent also modulates the transcription of insulin-responsive genes, inhibits macrophage and monocyte activation, and stimulates adipocyte differentiation."
            },
            "drugInfoSummaryLink": null,
            "nciConceptId": "C2583",
            "nciConceptName": "Rosiglitazone Maleate",
            "termId": 37793,
            "name": "rosiglitazone maleate",
            "firstLetter": "r",
            "type": "DrugTerm",
            "termNameType": "PreferredName",
            "prettyUrlName": "rosiglitazone-maleate"
        },
        {
            "aliases": [
                {
                    "type": "USBrandName",
                    "name": "Rezulin"
                },
                {
                    "type": "ChemicalStructureName",
                    "name": "5-[4-[(6-Hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy]benzyl]-2,4-thiazolidinedione"
                },
                {
                    "type": "ChemicalStructureName",
                    "name": "5-[[4-[4(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl\\-2,4-thiazolidinedione"
                },
                {
                    "type": "CodeName",
                    "name": "CI-991"
                },
                {
                    "type": "CodeName",
                    "name": "CS-045"
                },
                {
                    "type": "USBrandName",
                    "name": "Prelay"
                },
                {
                    "type": "USBrandName",
                    "name": "Romozin"
                },
                {
                    "type": "CASRegistryName",
                    "name": "97322-87-7"
                }
            ],
            "definition": {
                "html": "An orally-active thiazolidinedione with antidiabetic and hepatotoxic properties and potential antineoplastic activity.  Troglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis.  This agent also modulates the transcription of insulin-responsive genes, inhibits macrophage and monocyte activation, and stimulates adipocyte differentiation.",
                "text": "An orally-active thiazolidinedione with antidiabetic and hepatotoxic properties and potential antineoplastic activity.  Troglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis.  This agent also modulates the transcription of insulin-responsive genes, inhibits macrophage and monocyte activation, and stimulates adipocyte differentiation."
            },
            "drugInfoSummaryLink": null,
            "nciConceptId": "C1522",
            "nciConceptName": "Troglitazone",
            "termId": 42706,
            "name": "troglitazone",
            "firstLetter": "t",
            "type": "DrugTerm",
            "termNameType": "PreferredName",
            "prettyUrlName": "troglitazone"
        }
    ],
    "links": null
}